Clinical Trial Update: Differential Thrombogenesis by EPA and DHA Mediated by HDL [EARLY_Phase 1]

View source ↗

Summary

Early-phase trial evaluating differential thrombogenesis by EPA versus DHA mediated by HDL in lipid metabolism disorders, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• DHA (docosahexaenoic acid) (docosahexaenoic acid)
• EPA (eicosapentaenoic acid) (eicosapentaenoic acid)

Snippet

Sponsor: The Miriam Hospital | Conditions: Lipid Metabolism Disorders, Hypertriglyceridemia | EARLY_Phase 1 | Status: RECRUITING